Hepatology

Latest News

Arun Sanyal, MD | Credit: Virginia Commonwealth University
REGENERATE: Final Results for Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to NASH

May 21st 2024

End-of-study results from the phase 3 REGENERATE study were presented at DDW and highlight obeticholic acid’s trend in benefit for clinical outcomes.

| Image Credit: LinkedIn
Microbiota-Focused Dietary Modulation May Improve MAFLD Management

May 19th 2024

Rohit Loomba, MD | Credit: ACG
Study Assesses Predictive Markers of Resmetirom Histological Response in MAESTRO-NASH

May 19th 2024

Cynthia Levy, MD | Credit: Miami Miller School of Medicine
Cynthia Levy, MD: Interim ASSURE Data Suggest Seladelpar Could Be “Transformative” in PBC

May 18th 2024

ASSURE: Seladelapr Achieves Clinical Improvement in Primary Biliary Cholangitis
ASSURE: Seladelpar Achieves Clinical Improvement in Primary Biliary Cholangitis

May 18th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.